Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ITIL-306 |
Trade Name | |
Synonyms | ITIL 306|ITIL306|Autologous CoStAR-TILs ITIL-306 |
Drug Descriptions |
ITIL-306 comprises autologous tumor infiltrating lymphocytes engineered to express a costimulatory antigen receptor targeting FOLR1 as well as the CD28 and CD40 costimulatory domains, which potentially induce killing of FOLR1-expressing tumor cells and enhance antitumor immune response (Journal for ImmunoTherapy of Cancer 2022;10, NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C188248 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ITIL-306 | ITIL-306 | 0 | 1 |